Upstream Bio, Inc. (NASDAQ:UPB) Major Shareholder Ai Upstream Llc Buys 1,175,000 Shares

Upstream Bio, Inc. (NASDAQ:UPB) major shareholder Ai Upstream Llc bought 1,175,000 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was purchased at an average price of $17.00 per share, for a total transaction of $19,975,000.00. Following the completion of the purchase, the insider now directly owns 1,175,000 shares in the company, valued at $19,975,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Upstream Bio Trading Down 0.1 %

NASDAQ:UPB traded down $0.03 during midday trading on Thursday, reaching $23.60. The stock had a trading volume of 420,713 shares, compared to its average volume of 479,653. Upstream Bio, Inc. has a 1-year low of $20.74 and a 1-year high of $24.35.

Upstream Bio Company Profile

Upstream Bio, Inc, a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease.